Calculating supplementary protection certificate term
In 1993, a system of effectively extending the patent term of protection for pharmaceutical products was introduced by the supplementary protection certificate (SPC), Council Regulation (EEC) No 1768/92.
The purpose of the extensions made possible by this legislation was to remedy the problem that the term of patent monopoly for many medicinal products is largely eroded as the patentee or their licensee awaits the grant of a marketing authorisation. This could result in a proprietor having little or no patent term remaining by the time he or she is able to reach the market with the related product.
The SPC regulation is intended to address this problem by providing for up to five years’ further monopoly protection for specific patented ‘products’, as defined.
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
This short article surveys some key news from Pierre Tallot who heads up the Taylor Wessing RCR practice in France.
Appointment as a trust special administrator to an NHS trust does not give rise to a power to take any action or make any recommendations in relation to any other NHS trust.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town